Teva Pharmaceutical Industries

URI: https://gptkb.org/entity/Teva_Pharmaceutical_Industries
GPTKB entity
Statements (52)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Actavis_Generics
gptkb:Barr_Pharmaceuticals
gptkb:Ivax_Corporation
gptkbp:businessModel multinational
gptkbp:CEO gptkb:Richard_Francis
gptkbp:chairman gptkb:Amir_Elstein
gptkbp:founded 1901
gptkbp:founder gptkb:Chaim_Salomon
gptkb:Moshe_Levin
gptkb:Yitschak_Elstein
gptkbp:headquarters_location gptkb:Petah_Tikva
gptkbp:headquartersLocation gptkb:Israel
https://www.w3.org/2000/01/rdf-schema#label Teva Pharmaceutical Industries
gptkbp:industry pharmaceuticals
gptkbp:ISIN IL0006290147
gptkbp:language gptkb:Hebrew
English
gptkbp:legalForm gptkb:public_company
gptkbp:listedOn gptkb:TA-35_Index
gptkb:S&P_500
gptkbp:main_therapeutic_areas oncology
women's health
pain management
central nervous system
cardiovascular
respiratory
gptkbp:market one of the world's largest generic drug manufacturers
gptkbp:netIncome $-2.3 billion (2023)
gptkbp:notableProduct gptkb:Ajovy
gptkb:Austedo
gptkb:Copaxone
gptkbp:numberOfEmployees about 37,000
gptkbp:parentCompany none (independent)
gptkbp:products generic drugs
over-the-counter drugs
specialty medicines
gptkbp:regulatory_issues opioid litigation settlements
price-fixing investigations
gptkbp:revenue $15.8 billion (2023)
gptkbp:servesArea worldwide
gptkbp:stockExchange gptkb:New_York_Stock_Exchange
gptkb:Tel_Aviv_Stock_Exchange
gptkbp:stockSymbol gptkb:TEVA
gptkbp:subsidiary gptkb:Teva_API
gptkb:Teva_Canada_Limited
gptkb:Teva_Czech_Industries
gptkb:Teva_Pharmaceuticals_USA
gptkb:Teva_UK_Limited
gptkbp:website https://www.tevapharm.com/
gptkbp:bfsParent gptkb:Warren_Buffett
gptkbp:bfsLayer 4